NCT01834924

Improving Communication of Medication Instructions to Parents

Completed NA Last updated 20 October 2022

What this trial tests

NA trial testing HELPix in Medication Errors in 1,196 participants. Completed in 9 January 2015.

Timeline

31 May 2010

Primary endpoint
9 January 2015

9 January 2015

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	single
Primary purpose	health services research
Enrollment	1,196
Start date	31 May 2010
Primary completion	9 January 2015
Estimated completion	9 January 2015
Sites	2 locations across United States

Drugs / interventions tested

• HELPix

Conditions studied

• Medication Errors — all drugs for Medication Errors →
• Medication Adherence — all drugs for Medication Adherence →

Sponsor

NYU Langone Health — full company profile →

Who can join

18 and older, any sex, with Medication Errors or Medication Adherence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administering medications to their children; difficulty understanding provider medication instructions is likely to contribute to errors.

To address these issues, bilingual (English/Spanish), low literacy, picture-based medication instruction sheets were developed. This study will look at the effectiveness and feasibility of the medication instruction sheet-based intervention as it is used by providers in 2 pediatric emergency department settings, as part of a planned roll out of HELPix within the hospital system. The investigators hypothesize that there will be reduced medication dosing errors, improved medication adherence, reduced hospital revisit rates, and improved provider-parent communication. The investigators also hypothesize that provider technology experience, knowledge, and attitudes, will affect the extent to which providers use the tool.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.